Panbela Therapeutics Significato medio
Cos'è Significato medio di Panbela Therapeutics?
Significato medio di Panbela Therapeutics Inc. è 2.50
Qual è la definizione di Significato medio?
La media di raccomandazione è la media delle valutazioni degli analisti sul titolo che vanno da 1,0 (strong buy) a 5.0 (strong sell).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Significato medio di aziende nel Health Care settore su NASDAQ rispetto a Panbela Therapeutics
Cosa fa Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Aziende con significato medio simili a Panbela Therapeutics
- Revvity ha Significato medio di 2.47
- Cardinal Health ha Significato medio di 2.47
- Cintas ha Significato medio di 2.47
- Textron ha Significato medio di 2.47
- Ralph Lauren Corp ha Significato medio di 2.48
- NOV Inc ha Significato medio di 2.48
- Panbela Therapeutics ha Significato medio di 2.50
- Landbridge ha Significato medio di 2.52
- Urban Outfitters ha Significato medio di 2.52
- Wells Fargo & Co ha Significato medio di 2.52
- United Airlines Inc ha Significato medio di 2.52
- Cognizant Technology Solutions ha Significato medio di 2.52
- Grupo Aeroportuario Del Pacifico SAB de CV ha Significato medio di 2.53